09 5月 2018 by admin in UncategorizedComments resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly
30 4月 2018 by admin in UncategorizedComments Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing
29 3月 2018 by admin in UncategorizedComments resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results
